Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial

Int J STD AIDS. 2019 Oct;30(12):1156-1162. doi: 10.1177/0956462419865829. Epub 2019 Sep 27.
No abstract available

Keywords: Brazil; Cerebral toxoplasmosis; toxoplasmic encephalitis; treatment; trimethoprim-sulfamethoxazole.

Publication types

  • Clinical Trial

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Adult
  • Aged
  • Anti-Infective Agents / adverse effects*
  • Anti-Infective Agents / therapeutic use
  • Brain / diagnostic imaging*
  • Brazil
  • Female
  • HIV Infections / complications*
  • Humans
  • Male
  • Middle Aged
  • Neuroimaging
  • Tomography, X-Ray Computed / methods*
  • Toxoplasmosis, Cerebral / drug therapy*
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects*
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Infective Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination